Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients

Figure 1 Flow chart of the study. ¹Severity of the diseases is based on the World Health Organization, Classification. COVID-19: Coronavirus Disease 2019 (COVID-19); ALT: Alanine aminotransferase. ALT cut of value was defined as patients having ALT levels greater than 25 U/L for women and 35 U/L for men, according to the AASLD definitions.

Figure 2 Standardized forest plot comparing selected clinical variables between elevated ALT and normal ALT among hospitalized. ALT: Alanine aminotransferase.

Figure 3 Kaplan-Meier analysis showed the association of abnormal liver chemistry results among patients with COVID-19. ALT: Alanine aminotransferase; AST: aspartate aminotransferase.